Aflac Incorporated (NYSE:AFL) Shares Sold by Tompkins Financial Corp

Tompkins Financial Corp decreased its position in shares of Aflac Incorporated (NYSE:AFL) by 82.8% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 333 shares of the financial services provider’s stock after selling 1,600 shares during the quarter. Tompkins Financial Corp’s holdings in Aflac were worth $37,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in AFL. Y.D. More Investments Ltd acquired a new position in shares of Aflac in the 2nd quarter valued at $25,000. Catalyst Capital Advisors LLC acquired a new position in Aflac in the third quarter valued at $51,000. Valued Wealth Advisors LLC increased its stake in Aflac by 116.7% in the third quarter. Valued Wealth Advisors LLC now owns 479 shares of the financial services provider’s stock valued at $54,000 after purchasing an additional 258 shares during the period. Fairscale Capital LLC purchased a new stake in shares of Aflac in the second quarter valued at about $54,000. Finally, Cedar Wealth Management LLC acquired a new stake in shares of Aflac during the first quarter worth about $50,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

NYSE:AFL opened at $108.27 on Friday. The company has a current ratio of 0.08, a quick ratio of 0.10 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $60.15 billion, a P/E ratio of 16.31, a price-to-earnings-growth ratio of 2.11 and a beta of 0.96. The firm has a 50-day moving average price of $110.33 and a two-hundred day moving average price of $98.56. Aflac Incorporated has a twelve month low of $75.07 and a twelve month high of $115.50.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, topping analysts’ consensus estimates of $1.69 by $0.47. Aflac had a net margin of 22.02% and a return on equity of 16.34%. The business had revenue of $2.95 billion during the quarter, compared to analysts’ expectations of $4.30 billion. During the same period last year, the company posted $1.84 EPS. The company’s revenue was down 40.4% on a year-over-year basis. As a group, research analysts expect that Aflac Incorporated will post 7.17 earnings per share for the current fiscal year.

Aflac Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Wednesday, November 20th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.85%. Aflac’s dividend payout ratio (DPR) is 30.12%.

Analyst Ratings Changes

AFL has been the subject of several analyst reports. Evercore ISI upped their price objective on Aflac from $84.00 to $90.00 and gave the company an “underperform” rating in a research note on Thursday, September 26th. Truist Financial increased their price target on Aflac from $100.00 to $105.00 and gave the stock a “hold” rating in a report on Friday, November 1st. Wells Fargo & Company lifted their target price on shares of Aflac from $106.00 to $107.00 and gave the company an “equal weight” rating in a report on Tuesday, November 5th. JPMorgan Chase & Co. boosted their price target on shares of Aflac from $85.00 to $90.00 and gave the stock a “neutral” rating in a research note on Thursday, October 3rd. Finally, Bank of America lifted their price objective on Aflac from $115.00 to $124.00 and gave the company a “buy” rating in a report on Thursday, October 10th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, Aflac has an average rating of “Hold” and an average target price of $97.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.